First i-Stent MIGS Surgery Performed in Jamshedpur by Dr. Nitesh Singh at ASG Eye Hospitals

First i-Stent MIGS Surgery Performed in Jamshedpur by Dr. Nitesh Singh at ASG Eye Hospitals

Jamshedpur, Jharkhand – March 27, 2026 – ASG Eye Hospitals, a leading chain of super-specialty eye care facilities, proudly announces a groundbreaking achievement in glaucoma treatment. Dr. Nitesh Singh, COO and Regional Director of ASG Eye Hospitals Jamshedpur, successfully performed the first-ever i-Stent Micro-Invasive Glaucoma Surgery (MIGS) in the city of Jamshedpur.

This advanced procedure marks a significant step forward in providing cutting-edge, minimally invasive care for patients suffering from glaucoma, a leading cause of irreversible blindness worldwide.

The i-Stent (or iStent inject®) is a revolutionary trabecular micro-bypass device—the smallest medical implant used in the human body. Made of biocompatible titanium and heparin-coated for safety, it is implanted through a tiny incision (often during cataract surgery) to create a permanent pathway that enhances the eye’s natural fluid drainage. By bypassing blockages in the trabecular meshwork and restoring outflow to Schlemm’s canal, the procedure effectively lowers intraocular pressure (IOP) with a highly favorable safety profile.

Unlike traditional glaucoma surgeries, which can involve more extensive interventions and higher risks, MIGS with i-Stent offers:

  • Minimal tissue disruption
  • Rapid recovery
  • Reduced dependence on glaucoma eye drops
  • Excellent long-term outcomes supported by extensive clinical evidence and peer-reviewed studies

This achievement reflects our commitment to bringing world-class, innovative treatments to the people of Jamshedpur and surrounding regions,” said Dr. Nitesh Singh. “Glaucoma often progresses silently, but with procedures like i-Stent MIGS, we can now offer safer, more effective options to preserve vision and improve quality of life for our patients. We are proud to be the first in the city to introduce this gold-standard technology.”

ASG Eye Hospitals continues to prioritize patient-centric care, adopting the latest global advancements in eye health. This milestone underscores the hospital’s dedication to excellence and accessibility in specialized treatments.

For more information about i-Stent MIGS, glaucoma management, or to schedule a consultation, please contact:

ASG Eye Hospitals, Jamshedpur

Ambagan, Sakchi, Jamshedpur, Jharkhand

Phone: 1800 1211 804 | 0657-244505 | 0657-244404

Latest Technology of glaucoma treatment at MediVision

Latest Technology of glaucoma treatment at MediVision

MediVision eye care centre, a trusted NABH accredited super-specialty eye hospital in Hyderabad, is thrilled to announce introduction of the revolutionary iStent Inject and iStent Inject W technology for treatment of glaucoma and cataract patients.

Glaucoma nicknamed the “Silent Thief of Sight” is one of the world’s most common cause of irreversible blindness. Traditional treatment includes use of long-term medication in the form of eyedrops or invasive surgery, both of which have potential side effects and complications. MIGS (Minimally Invasive Glaucoma Surgery) as the name suggest offers a less invasive, safer alternative for treatment of glaucoma, making it more manageable and less cumbersome for patients. iStent Inject is the most cutting edge MIGS, especially benefitting patients with mild to moderate glaucoma, offering freedom from multiple medication.

Benefits of iStent technology for glaucoma patients:

  1. High safety profile, less invasive option with minimal alteration of normal anatomy
  2. Minimal post operative discomfort, quick recover, fewer complications
  3. Advantage of being combined with cataract procedure in a single sitting

Expert Endorsements:

Dr. Rupak Kumar Reddy, senior Cataract surgeon has recently implanted the iStent Inject. He highlights the ease of its use, advantage of no additional incisions and high safety profile.

Dr. Meena Thotakura, Glaucoma consultant and surgeon, also shared her experience with the iStent Inject, stating that it will be a boon for patients, especially those in earlier stages, where they would have had to use lifelong anti glaucoma medications.

About MediVision eye care Centre:

MediVision Eye Care Centre is a trusted NABH Accredited Super-Specialty Eye Hospital established in 1993 by renowned ophthalmologist Dr. K. Ravi Kumar Reddy. With over 31 years of dedicated service. They have performed more than 135,000 successful eye procedures, driven by their commitment to provide top-quality and affordable eye care services to all.

Our expert team of 20 doctors and 200 support staff provide comprehensive patient care with emphasis on compassion, integrity and excellence. Their 50-bedded Super-specialty Eye Hospital equipped with state-of-the-art infrastructure including Robotic Cataract surgery unit, World class refractive centre including the latest SILK- ELITA, offers various solutions for cataract, glaucoma, corneal and Vitreo retinal problems, all under a single roof.